Impact of Clinicopathological Features on Survival in Patients Treated with First-line Immune Checkpoint Inhibitors Plus Tyrosine Kinase Inhibitors for Renal Cell Carcinoma: A Meta-analysis of Randomized Clinical Trials
Alessandro Rizzo, Veronica Mollica, Matteo Santoni, Angela Dalia Ricci, Matteo Rosellini, Andrea Marchetti, Rodolfo Montironi, Andrea Ardizzoni, Francesco Massari
Topics & Concepts
MedicineSunitinibInternal medicineHazard ratioRenal cell carcinomaClinical endpointOncologyRandomized controlled trialCochrane LibraryMeta-analysisConfidence intervalRenal cell carcinoma treatmentCancer Immunotherapy and BiomarkersFerroptosis and cancer prognosis